Back to Insider Trading View Full Company Profile

TERN

MODERATE

Terns Pharmaceuticals, Inc.

CIK: 0001831363

Strong Sell (90% confidence)

Last activity: 5 days ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$40.05M

Insider Roster (2 total, 2 active)

Insider Buys Sells Net Value Holdings
Burroughs Amy L.
Chief Executive Officer
0 8 -$6.52M
291,746 shares
$13.59M
Kuriakose Emil
Chief Medical Officer
0 3 -$94K
105,673 shares
$5.57M

Recent Transactions

SELL Kuriakose Emil (Chief Medical Officer)

942 shares @ $52.75

$50K

Apr 1, 2026

Conviction: | View SEC Filing →
SELL Burroughs Amy L. (Chief Executive Officer)

11,813 shares @ $46.57

$550K

Mar 16, 2026

Conviction: | View SEC Filing →
SELL Burroughs Amy L. (Chief Executive Officer)

2,770 shares @ $47.30

$131K

Mar 16, 2026

Conviction: | View SEC Filing →
SELL Burroughs Amy L. (Chief Executive Officer)

8,159 shares @ $39.22

$320K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Burroughs Amy L. (Chief Executive Officer)

4,083 shares @ $39.80

$163K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Burroughs Amy L. (Chief Executive Officer)

2,341 shares @ $38.07

$89K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Burroughs Amy L. (Chief Executive Officer)

61,228 shares @ $37.02

$2.27M

Jan 15, 2026

Conviction: | View SEC Filing →
SELL Burroughs Amy L. (Chief Executive Officer)

7,521 shares @ $37.53

$282K

Jan 15, 2026

Conviction: | View SEC Filing →
SELL Burroughs Amy L. (Chief Executive Officer)

71,339 shares @ $38.10

$2.72M

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Kuriakose Emil (Chief Medical Officer)

955 shares @ $38.36

$37K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Kuriakose Emil (Chief Medical Officer)

200 shares @ $39.60

$8K

Jan 2, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.